1. Home
  2. RMBS vs IOVA Comparison

RMBS vs IOVA Comparison

Compare RMBS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMBS
  • IOVA
  • Stock Information
  • Founded
  • RMBS 1990
  • IOVA 2007
  • Country
  • RMBS United States
  • IOVA United States
  • Employees
  • RMBS N/A
  • IOVA N/A
  • Industry
  • RMBS Semiconductors
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RMBS Technology
  • IOVA Health Care
  • Exchange
  • RMBS Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • RMBS 8.0B
  • IOVA 975.1M
  • IPO Year
  • RMBS 1997
  • IOVA N/A
  • Fundamental
  • Price
  • RMBS $94.88
  • IOVA $2.27
  • Analyst Decision
  • RMBS Strong Buy
  • IOVA Buy
  • Analyst Count
  • RMBS 5
  • IOVA 11
  • Target Price
  • RMBS $86.60
  • IOVA $11.90
  • AVG Volume (30 Days)
  • RMBS 1.7M
  • IOVA 10.9M
  • Earning Date
  • RMBS 10-27-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • RMBS N/A
  • IOVA N/A
  • EPS Growth
  • RMBS 0.94
  • IOVA N/A
  • EPS
  • RMBS 2.11
  • IOVA N/A
  • Revenue
  • RMBS $645,488,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • RMBS $27.27
  • IOVA $67.40
  • Revenue Next Year
  • RMBS $13.32
  • IOVA $56.32
  • P/E Ratio
  • RMBS $44.94
  • IOVA N/A
  • Revenue Growth
  • RMBS 35.17
  • IOVA 636.99
  • 52 Week Low
  • RMBS $38.01
  • IOVA $1.64
  • 52 Week High
  • RMBS $100.73
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • RMBS 73.29
  • IOVA 45.40
  • Support Level
  • RMBS $72.45
  • IOVA $2.27
  • Resistance Level
  • RMBS $89.98
  • IOVA $2.46
  • Average True Range (ATR)
  • RMBS 4.71
  • IOVA 0.14
  • MACD
  • RMBS 1.69
  • IOVA -0.01
  • Stochastic Oscillator
  • RMBS 80.39
  • IOVA 33.33

About RMBS Rambus Inc.

Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: